Latest News about BIIB
Recent news which mentions BIIB
Why Is Biogen (BIIB) Stock Up 40% Today?
September 28, 2022
From InvestorPlace
Medicare coverage of Eisai and Biogen’s promising new Alzheimer’s therapy is ‘another bridge to cross’
September 28, 2022
From MarketWatch
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2022
September 28, 2022
From Benzinga
These Analysts Boost Price Targets On Biogen Following Positive Alzheimer's Drug Data, Shares Jump
September 28, 2022
Tickers
BIIB
From Benzinga
From Benzinga
A Biotech Breakthrough Means Big Gains for These 2 Stocks
September 28, 2022
From Motley Fool
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 28, 2022
From Benzinga
Is iPhone Demand Really Slowing Down?, Lyft Freezes Hiring, Biogen's New Drug Slows Alzheimer's Progression: Top Financial Media Stories Wednesday, Sept. 28
September 28, 2022
From Benzinga
What In The World Is Going On With Biogen (BIIB) Shares?
September 28, 2022
From Benzinga
From InvestorPlace
Why Cassava Sciences Shares Are Soaring Higher
September 28, 2022
From Benzinga
What's Going On With Eli Lilly Stock Shooting Higher Today
September 28, 2022
From Benzinga
From Benzinga
Nasdaq Futures Slip But S&P 500, Dow Futures Hold Up Ahead Of Market Open — Apple, Biogen Stocks In Focus
September 28, 2022
From Benzinga
Here’s why one strategist says the consumer and related stocks might get a second wind
September 28, 2022
From MarketWatch
Why Biogen Stock Is Up 40% Today
September 28, 2022
From Benzinga
Biogen, Eli Lilly And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
September 28, 2022
From Benzinga
2 Sympathy Plays To Watch For In The Wake Of Biogen's Positive Alzheimer's Drug Data
September 28, 2022
From Benzinga
US Stock Futures Down Ahead Of Fed Speakers, Economic Data
September 28, 2022
From Benzinga
Regulatory approval is next: Mizuho lifts Biogen to buy on news of Alzheimer’s drug success
September 28, 2022
From MarketWatch
Eisai shares indicated sharply higher after trial of experimental drug slows Alzheimer’s progression
September 28, 2022
From MarketWatch
Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
September 28, 2022
From Benzinga
Alzheimer’s drug from Eisai, Biogen shows promise in large trial
September 27, 2022
Tickers
BIIB
From MarketWatch
Elon Musk Twitter Case Deposition Delayed, FTX US Goes Shopping, Spotify's Analyst Sees Audiobooks Immaterial: Top Financial Media Stories Tuesday, Sept. 27
September 27, 2022
From Benzinga
DOJ says Biogen agrees to $900 million settlement over allegations of false Medicare claims
September 26, 2022
Tickers
BIIB
Tags
BIIB
From MarketWatch
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.